Skip to main content

Main menu

  • Content
    • Current Issue
    • Advance Access
    • Archive
    • Supplements
    • Special Collections
    • Topic Collections
  • For Authors
    • Instructions for Authors
    • Tips for Writing About Programs in GHSP
      • Local Voices Webinar
      • Connecting Creators and Users of Knowledge
    • Submit Manuscript
    • Publish a Supplement
    • Promote Your Article
    • Resources for Writing Journal Articles
  • About
    • About GHSP
    • Editorial Team
    • Advisory Board
    • FAQs
    • Instructions for Reviewers

User menu

  • My Alerts

Search

  • Advanced search
Global Health: Science and Practice
  • My Alerts

Global Health: Science and Practice

Dedicated to what works in global health programs

Advanced Search

  • Content
    • Current Issue
    • Advance Access
    • Archive
    • Supplements
    • Special Collections
    • Topic Collections
  • For Authors
    • Instructions for Authors
    • Tips for Writing About Programs in GHSP
    • Submit Manuscript
    • Publish a Supplement
    • Promote Your Article
    • Resources for Writing Journal Articles
  • About
    • About GHSP
    • Editorial Team
    • Advisory Board
    • FAQs
    • Instructions for Reviewers
  • Alerts
  • Find GHSP on LinkedIn
  • Visit GHSP on Facebook
  • RSS
ORIGINAL ARTICLE
Open Access

Using Human-Centered Design to Explore Potential Users' and Men's Views of New Injectable Contraceptives in Kampala and Lagos

Holly M. Burke, Rebecca L. Callahan, Anna Lawton, Abigail Turinayo, Oluwatoyin Oyekenu, Sheila Niyonsaba, Oladunni Taiwo, Victor Muwonge Semaganda, Andy Awiti, Audrey Fratus, Fredrick Mubiru and Funmilola M. OlaOlorun
Global Health: Science and Practice December 2023, 11(6):e2300215; https://doi.org/10.9745/GHSP-D-23-00215
Holly M. Burke
aReproductive, Maternal, Newborn, Child Health, FHI 360, Durham, NC, USA.
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
  • For correspondence: hburke{at}fhi360.org
Rebecca L. Callahan
bProduct Development and Introduction, FHI 360, Durham, NC, USA.
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Anna Lawton
bProduct Development and Introduction, FHI 360, Durham, NC, USA.
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Abigail Turinayo
cDesign without Borders, Kampala, Uganda.
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Oluwatoyin Oyekenu
dSCOPE, Nigeria.
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Sheila Niyonsaba
cDesign without Borders, Kampala, Uganda.
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Oladunni Taiwo
dSCOPE, Nigeria.
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Victor Muwonge Semaganda
cDesign without Borders, Kampala, Uganda.
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Andy Awiti
eSCOPE, Kenya.
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Audrey Fratus
bProduct Development and Introduction, FHI 360, Durham, NC, USA.
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Fredrick Mubiru
fFHI 360, Kampala, Uganda.
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Funmilola M. OlaOlorun
gCollege of Medicine, University of Ibadan, Ibadan, Nigeria.
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
PreviousNext
  • Article
  • Figures & Tables
  • Supplements
  • Info & Metrics
  • Comments
  • PDF
Loading

Figures & Tables

Tables

  • Additional Files
    • View popup
    TABLE 1.

    Eligibility Criteria by Study Population for Market Research on 4- and 6-Month Injectable Contraceptive Methods, Kampala, Uganda, and Lagos, Nigeria

    Study PopulationEligibility Criteriaa
    Phase 1: Focus group discussions
        Injectable users 18–24 years
    • Current users of DMPA injectables

        Injectable users 25+ years
        Potential injectable users 18–24 years
    • Current users of modern methods other than injectables or sterilization

    • Previous injectable users willing to use again

    • Non- or never-users willing to consider DMPA injectables

        Potential injectable users 25+ years
        Men 18–24 years
    • Men who have not undergone a vasectomy and were in a sexual relationship with a woman

        Men 25+ years
    Phase 2: Cocreation workshop
        Recruited from focus group discussions
    • Injectable users

    • Potential injectable users

        Newly recruited from health facilities
    • Abbreviations: DMPA, depot medroxyprogesterone acetate.

    • ↵a In addition to the criteria in the table, all participants needed to be at least aged 18 years, provide informed consent, and agree to be audio-recorded.

    • View popup
    TABLE 2.

    Number of FGDs and Participants for Market Research of 4- and 6-Month Injectable Contraceptive Methods

    KampalaLagos
    FGDsParticipantsFGDsParticipants
    Injectable users 18–24 years21029
    Injectable users 25+ years210210
    Potential injectable users 18–24 years210212
    Potential injectable users 25+ years210212
    Men 18–24 yearsa13212
    Men 25+ yearsa28212
    Total11511267
    • Abbreviation: FGD, focus group discussion.

    • ↵a Male FGDs in Lagos were stratified by marital status. In Kampala, all participants in the 18–24-year-old male FGD were unmarried; one of the male 25+ groups included all married participants and the other included some unmarried and some married men.

    • View popup
    TABLE 3.

    Preferences for 4-Month and 6-Month Injectable Contraceptive Method

    BothKampalaLagos
    Perceived benefits of 4-month injectable
    • Fewer facility visits

    • Offered option to self-inject

    • Shorter reinjection window (grace period)

    –
    Perceived benefits of 6-month injectable
    • Fewer facility visits

    • Administered by health worker

    • Intermediate duration

    • Long duration

    Concerns about 4-month injectable
    • Side effects

    • Delayed return to fertility

    • Cost

    • Self-efficacy to self-inject

    • Stock-outs

    –
    • Shorter reinjection window (grace period)

    Concerns about 6-month injectable
    • Delayed return to fertility

    • Side effects

    • Cost

    –
    Target audience for 4-month injectable
    • Younger

    • Busy lifestyles

    • Limited access to facilities

    • Unmarried

    • Without children

    • Do not want long-acting reversible contraception

    • Frequent sexual activity

    • Married and unmarried

    • Wanting to space children

    Target audience for 6-month injectable
    • Older

    • Married

    • Has children

    • In committed relationship

    • Frequent sexual activity

    • Taking other medications

    • Young, single mothers wanting to avoid frequent facility visits

    Reasons for preferring 6-month injectable over 4-month injectable
    • Longer duration

    • Fewer facility visits

    • Easier to remember reinjection interval

    • Provider administered

    • Easier to differentiate

    ––
    Reasons for preferring 4-month injectable over 6-month injectable–
    • Intermediate duration

    • Broader appeal

    Ideal duration of injectables
    • 6–12 months

    ––
    Ideal number of injectable options
    • As many as needed to meet needs of users

    • 2 options (4- and 6-month) up to 12 options

    • 3 options (3-, 4-, and 6-month)

    • View popup
    TABLE 4.

    Marketing Elements for a 4-Month Injectable

    ElementKampalaLagos
    Positioning statementThe 4-month injection gives women the power and convenience to prevent unplanned pregnancy while they pursue their dreams.The 4-month injection supports women in taking full charge of the prevention of unplanned pregnancies, by offering them flexibility and peace of mind in a package that they can choose to use safely and easily, anytime and anywhere.
    Brand pillars
    • Method can be self-administered, which can ensure privacy particularly for those who face stigma accessing family planning.

    • The shorter grace period of 1 week is perceived as indicating quicker return to fertility.

    Control
    • Method can be self-administered anytime, anywhere.

    • Fewer visits to health facilities.

    • Requires less administrative action in comparison to daily pills and shorter term injectables.

    Ease of use
    • Easy to self-administer compared to other products in the market.

    • Easy to store safely, use, and dispose.

    Reliability
    • Guaranteed duration of effectiveness for 4 months.

    Brand promiseThe method will bring women no shame; it will foster excellence by giving women time and opportunity to grow and succeed at their plans, as well as giving them the flexibility to change their plans when they want to.Contraception for the woman who wants full control.
    Brand personality
    • The method needs to have an inclusive, aspirational, and creative personality.

    • The tone of the communication of the method should convey ambition and offer a sense of confidence and ability to reach new heights.

    • The style of the communication should portray real women from all parts of Uganda choosing the 4-month method in different seasons of life, such as university student at the start of the semester, home assistant starting a new job in the city, and a woman exploring a new relationship.

    • Stay calm, there's no need to panic anymore.

    • You hold the key - you decide.

    • Focus on your dreams.

    • Explore your options.

    • Take your time, at your pace.

    The following emotions should be associated with users of the method:
    • Happy and calm because they are less worried when having sex.

    • Hopeful due to availability of a solution to prevent unplanned pregnancies.

    • Afforded more flexibility (reduced visits to facility) and additional flexibility for those who preferred self-administration.

    The tone should be:
    • Friendly: relatable with a touch of humor.

    • Uplifting: inspiring, affirmative, and supportive of women.

    • Confident: open and proactively informative about the product.

    • View popup
    TABLE 5.

    Marketing Elements for a 6-Month Injectable

    ElementKampalaLagos
    Positioning statementOpportunity to create ideal child spacing at a reduced cost and with fewer visits to a facility.A contraceptive that offers busy women the certainty they need to plan long term and the time to do what matters most.
    Brand pillars
    • Low cost of being a twice/year method.

    • Long-acting pregnancy protection without having to use a long-acting reversible contraception, which are perceived by some to have adverse side effects including a long return to fertility.

    • No detectable presence in the body so can be used discreetly.

    • Liberating: only 2 facility visits per year and can be used discreetly.

    • Certainty: long duration allows users to make long-term plans.

    • Reliability: guaranteed duration of effectiveness for 6 months.

    Brand promiseWill foster the healthy growth of one's family by providing a pregnancy prevention method for an adequate duration between pregnancies. This promise helps fulfill the parental desire of dedicated time to nurturing their children—more than providing basics but also building deep relationships with them.Contraception for the woman who wants the certainty to pursue more in life.
    Brand personality
    • This method needs to have a frugal, trustworthy, responsible, and family-oriented personality.

    • The tone of the communication of the new 6-month method should therefore convey joy with a stress-free approach to family life, providing comfort and security to a home.

    • The communication style should portray different stages of family life; from the couple deciding together, to the birth of the first child, and the steady growth of the family.

    • Stress free and pocket-friendly.

    • Providing a sense of priority and wise living.

    • Dedication and strong commitment to a healthy family.

    • We are stronger together.

    • Open communication that is easy to understand.

    The following emotions should be associated with users of the method:
    • Peace of mind because of the long duration of effectiveness.

    • Achieving the “good life” by supporting child spacing and reducing strain on resources.

    • Safety because it is administered at a health facility.

    • Allowing for regular intimacy due to longer duration.

    The tone should be:
    • Friendly: relatable, with a touch of humor.

    • Uplifting: inspiring, affirmative, and supportive of women.

    • Assertive: reinforcing certainty and conviction of the woman's decision-making.

    • Confident: open and proactively informative about the product.

Additional Files

  • Tables
  • Supplemental material

    • Supplement -

      Supplement

PreviousNext
Back to top

In this issue

Global Health: Science and Practice: 11 (6)
Global Health: Science and Practice
Vol. 11, No. 6
December 22, 2023
  • Table of Contents
  • About the Cover
  • Index by Author
Print
Download PDF
Article Alerts
Sign In to Email Alerts with your Email Address
Email Article

Thank you for your interest in spreading the word about Global Health: Science and Practice.

NOTE: We only request your email address so that the person you are recommending the page to knows that you wanted them to see it, and that it is not junk mail. We do not capture any email address.

Enter multiple addresses on separate lines or separate them with commas.
Using Human-Centered Design to Explore Potential Users' and Men's Views of New Injectable Contraceptives in Kampala and Lagos
(Your Name) has forwarded a page to you from Global Health: Science and Practice
(Your Name) thought you would like to see this page from the Global Health: Science and Practice web site.
CAPTCHA
This question is for testing whether or not you are a human visitor and to prevent automated spam submissions.
Citation Tools
Using Human-Centered Design to Explore Potential Users' and Men's Views of New Injectable Contraceptives in Kampala and Lagos
Holly M. Burke, Rebecca L. Callahan, Anna Lawton, Abigail Turinayo, Oluwatoyin Oyekenu, Sheila Niyonsaba, Oladunni Taiwo, Victor Muwonge Semaganda, Andy Awiti, Audrey Fratus, Fredrick Mubiru, Funmilola M. OlaOlorun
Global Health: Science and Practice Dec 2023, 11 (6) e2300215; DOI: 10.9745/GHSP-D-23-00215

Citation Manager Formats

  • BibTeX
  • Bookends
  • EasyBib
  • EndNote (tagged)
  • EndNote 8 (xml)
  • Medlars
  • Mendeley
  • Papers
  • RefWorks Tagged
  • Ref Manager
  • RIS
  • Zotero
Share
Using Human-Centered Design to Explore Potential Users' and Men's Views of New Injectable Contraceptives in Kampala and Lagos
Holly M. Burke, Rebecca L. Callahan, Anna Lawton, Abigail Turinayo, Oluwatoyin Oyekenu, Sheila Niyonsaba, Oladunni Taiwo, Victor Muwonge Semaganda, Andy Awiti, Audrey Fratus, Fredrick Mubiru, Funmilola M. OlaOlorun
Global Health: Science and Practice Dec 2023, 11 (6) e2300215; DOI: 10.9745/GHSP-D-23-00215
del.icio.us logo Twitter logo Facebook logo Mendeley logo
  • Tweet Widget
  • Facebook Like
  • Google Plus One

Statistics from Altmetric.com

Jump to section

  • Article
    • ABSTRACT
    • BACKGROUND
    • METHODS
    • RESULTS
    • DISCUSSION
    • CONCLUSION
    • Acknowledgments
    • Funding
    • Disclaimer
    • Author contributions
    • Competing interests
    • Notes
    • REFERENCES
  • Figures & Tables
  • Supplements
  • Info & Metrics
  • Comments
  • PDF

Related Articles

  • PubMed
  • Google Scholar

Cited By...

  • Another Best Practice: Leveraging User and Stakeholder Perspectives to Improve and Refine Existing Medical Products
  • Service Delivery Considerations for Introducing New Injectable Contraceptives Lasting 4 and 6 Months in Nigeria and Uganda: A Qualitative Study
  • Google Scholar

More in this TOC Section

  • A Comprehensive Strategy to Mitigate Institutional Maternal Mortality: Lessons From a Quality Improvement Initiative in Brazilian Maternity Hospitals
  • Research and Learning Priorities for a Surgical Obstetrics and Family Planning Project Implementing in Low- and Middle-Income Countries: Results of an Expert Consultation
  • Uganda Public Health Fellowship Program’s Contributions to Malaria Control Programs 2015–2022: Strategies, Implementation Challenges, and Opportunities
Show more ORIGINAL ARTICLE

Similar Articles

Subjects

  • Health Topics
    • Family Planning and Reproductive Health
Johns Hopkins Center for Communication Programs

Follow Us On

  • LinkedIn
  • Facebook
  • RSS

Articles

  • Current Issue
  • Advance Access Articles
  • Past Issues
  • Topic Collections
  • Most Read Articles
  • Supplements

More Information

  • Submit a Paper
  • Instructions for Authors
  • Instructions for Reviewers

About

  • About GHSP
  • Advisory Board
  • FAQs
  • Privacy Policy
  • Contact Us

© 2026 Creative Commons Attribution 4.0 International License. ISSN: 2169-575X

Powered by HighWire